Interleukin-1 regulates follicular T cells during the germinal center reaction.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 28 02 2024
accepted: 26 04 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 10 6 2024
Statut: epublish

Résumé

Antibody production and the generation of memory B cells are regulated by T follicular helper (Tfh) and T follicular regulatory (Tfr) cells in germinal centers. However, the precise role of Tfr cells in controlling antibody production is still unclear. We have previously shown that both Tfh and Tfr cells express the IL-1R1 agonist receptor, whereas only Tfr cells express the IL-1R2 decoy and IL-1Ra antagonist receptors. We aimed to investigate the role of IL-1 receptors in the regulation of B cell responses by Tfh and Tfr. We generated mice with IL-1 receptors inactivated in Tfh or Tfr and measured antibody production and cell activation after immunisation. While IL-1β levels are increased in the draining lymph node after immunisation, antigen-specific antibody levels and cell phenotypes indicated that IL-1β can activate both Tfh and Tfr cells through IL-1R1 stimulation. Surprisingly, expression of IL-1R2 and IL-1Ra on Tfr cells does not block IL-1 activation of Tfh cells, but rather prevents IL-1/IL-1R1-mediated early activation of Tfr cells. IL-1Rs also regulate the antibody response to autoantigens and its associated pathophysiology in an experimental lupus model. Collectively, our results show that IL-1 inhibitory receptors expressed by Tfr cells prevent their own activation and suppressive function, thus licensing IL-1-mediated activation of Tfh cells after immunisation. Further mechanistic studies should unravel these complex interactions between IL-1β and follicular helper and regulatory T cells and provide new avenues for therapeutic intervention.

Identifiants

pubmed: 38855101
doi: 10.3389/fimmu.2024.1393096
pmc: PMC11157057
doi:

Substances chimiques

Receptors, Interleukin-1 Type I 0
Interleukin-1beta 0
Interleukin-1 0
IL1R1 protein, mouse 0
Receptors, Interleukin-1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1393096

Informations de copyright

Copyright © 2024 Belbezier, Engeroff, Fourcade, Vantomme, Vaineau, Gouritin, Bellier, Brocheriou, Tchitchek, Graff-Dubois and Klatzmann.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Aude Belbezier (A)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

Paul Engeroff (P)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

Gwladys Fourcade (G)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

Hélène Vantomme (H)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

Romain Vaineau (R)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

Bruno Gouritin (B)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

Bertrand Bellier (B)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.
Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France.

Isabelle Brocheriou (I)

Assistance Publique - Hôpitaux de Pari (AP-HP), Hôpital Pitié-Salpêtrière, Department of Pathology, Paris, France.

Nicolas Tchitchek (N)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

Stephanie Graff-Dubois (S)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

David Klatzmann (D)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.
Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH